Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (Prodige 12-accord 18-Unicancer GI): A randomized phase III study
Julien Edeline, Meher Benabdelghani, Aurélie Bertaut, Jérôme Watelet, Pascal Hammel, Jean Paul Joly, Karim Boudjema, Laetitia Fartoux, Karine Bouhier-Leporrier, Jean Louis Jouve, Roger Faroux, Véronique Guerin-Meyer, Jean Emmanuel Kurtz, Eric Assénat, Jean François Seitz, Isabelle Baumgaertner, David Tougeron, Christelle de la Fouchardière, Catherine Lombard-Bohas, Eveline BoucherTrevor Stanbury, Christophe Louvet, David Malka, Jean Marc Phelip
Research output: Contribution to journal › Article › peer-review
409Scopus
citations
Fingerprint
Dive into the research topics of 'Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (Prodige 12-accord 18-Unicancer GI): A randomized phase III study'. Together they form a unique fingerprint.